Phase 1/2 Study of Pemetrexed Plus Cisplatin in Unresectable, Advanced Gastric Carcinoma.
Latest Information Update: 01 Oct 2009
At a glance
- Drugs Pemetrexed (Primary) ; Cisplatin
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Eli Lilly and Company
- 24 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 13 Aug 2007 Status changed from recruiting to in progress.
- 05 May 2006 New trial record.